These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 26462979)

  • 1. Fibrinogen Level and Bleeding Risk During Catheter-Directed Thrombolysis Using Tissue Plasminogen Activator.
    Lee K; Istl A; Dubois L; DeRose G; Forbes TL; Wiseman D; Mujoomdar A; Kribs S; Power AH
    Vasc Endovascular Surg; 2015 Oct; 49(7):175-9. PubMed ID: 26462979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinogen level as a surrogate for the outcome of thrombolytic therapy using tissue plasminogen activator for acute lower extremity intravascular thrombosis.
    Skeik N; Gits CC; Ehrenwald E; Cragg AH
    Vasc Endovascular Surg; 2013 Oct; 47(7):519-23. PubMed ID: 23899656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound-accelerated thrombolysis in arterial and venous peripheral occlusions: fibrinogen level effects.
    Raabe RD
    J Vasc Interv Radiol; 2010 Aug; 21(8):1165-72. PubMed ID: 20656221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of periprocedural hypertension and adverse outcomes in patients undergoing catheter-directed thrombolysis.
    Agle SC; McNally MM; Powell CS; Bogey WM; Parker FM; Stoner MC
    Ann Vasc Surg; 2010 Jul; 24(5):609-14. PubMed ID: 20413257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of catheter-directed thrombolysis for deep venous thrombosis in cancer patients.
    Kim HS; Preece SR; Black JH; Pham LD; Streiff MB
    J Vasc Surg; 2008 Feb; 47(2):388-94. PubMed ID: 18241762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombolysis of acute peripheral arterial and venous occlusions with tenecteplase and eptifibatide: a pilot study.
    Burkart DJ; Borsa JJ; Anthony JP; Thurlo SR
    J Vasc Interv Radiol; 2003 Jun; 14(6):729-33. PubMed ID: 12817039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinogen and catheter-directed thrombolysis.
    Ross RL; Beck AW
    Semin Vasc Surg; 2014 Dec; 27(3-4):182-95. PubMed ID: 26073829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of catheter-delivered plasmin in patients with acute lower extremity arterial or bypass graft occlusion: phase I results.
    Marder VJ; Comerota AJ; Shlansky-Goldberg RD; Davis JP; Deng C; Hanna K; Fineberg D
    J Thromb Haemost; 2012 Jun; 10(6):985-91. PubMed ID: 22487025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endovascular venous thrombolysis in children younger than 24 months.
    Kukreja KU; Lungren MP; Patel MN; Johnson ND; Racadio JM; Dandoy C; Tarango C
    J Vasc Interv Radiol; 2014 Aug; 25(8):1158-64. PubMed ID: 24909354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial clinical results of tenecteplase (TNK) in catheter-directed thrombolytic therapy.
    Razavi MK; Wong H; Kee ST; Sze DY; Semba CP; Dake MD
    J Endovasc Ther; 2002 Oct; 9(5):593-8. PubMed ID: 12431142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased risk of renal dysfunction with percutaneous mechanical thrombectomy compared with catheter-directed thrombolysis.
    Morrow KL; Kim AH; Plato SA; Shevitz AJ; Goldstone J; Baele H; Kashyap VS
    J Vasc Surg; 2017 May; 65(5):1460-1466. PubMed ID: 27876521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and outcomes of thrombolysis with tissue plasminogen activator for treatment of intravascular thrombosis in children.
    Gupta AA; Leaker M; Andrew M; Massicotte P; Liu L; Benson LN; McCrindle BW
    J Pediatr; 2001 Nov; 139(5):682-8. PubMed ID: 11713447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low dose tissue plasminogen activator treatment for vascular thrombosis following cardiac catheterization in children: a single center experience.
    Bratincsák A; Moore JW; El-Said HG
    Catheter Cardiovasc Interv; 2013 Nov; 82(5):782-5. PubMed ID: 22718305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complications associated with the use of urokinase and recombinant tissue plasminogen activator for catheter-directed peripheral arterial and venous thrombolysis.
    Ouriel K; Gray B; Clair DG; Olin J
    J Vasc Interv Radiol; 2000 Mar; 11(3):295-8. PubMed ID: 10735422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma Fibrinogen Change as a Predictor of Major Bleeding During Catheter-Directed Thrombolysis.
    Dorey T; Kong D; Lobo W; Hanlon E; Abramowitz S; Turcotte J; Jeyabalan G
    Ann Vasc Surg; 2024 Feb; 99():262-271. PubMed ID: 37802144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasound-Assisted Catheter-Directed Thrombolysis for Submassive Pulmonary Embolism.
    Mohan PP; Manov JJ; Contreras F; Langston ME; Doshi MH; Narayanan G
    Vasc Endovascular Surg; 2018 Apr; 52(3):195-201. PubMed ID: 29436310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinogen degradation coagulopathy and bleeding complications after stroke thrombolysis.
    Matosevic B; Knoflach M; Werner P; Pechlaner R; Zangerle A; Ruecker M; Kirchmayr M; Willeit J; Kiechl S
    Neurology; 2013 Mar; 80(13):1216-24. PubMed ID: 23486872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombolytic therapy for deep vein thrombosis: potential application of plasmin.
    Marder VJ
    Thromb Res; 2009; 123 Suppl 4():S56-61. PubMed ID: 19303506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety, efficacy, and pharmacoeconomics of low-dose alteplase compared with urokinase for catheter-directed thrombolysis of arterial and venous occlusions.
    Sugimoto K; Hofmann LV; Razavi MK; Kee ST; Sze DY; Dake MD; Semba CP
    J Vasc Surg; 2003 Mar; 37(3):512-7. PubMed ID: 12618684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinogen decrease after intravenous thrombolysis in ischemic stroke patients is a risk factor for intracerebral hemorrhage.
    Vandelli L; Marietta M; Gambini M; Cavazzuti M; Trenti T; Cenci MA; Casoni F; Bigliardi G; Pentore R; Nichelli P; Zini A
    J Stroke Cerebrovasc Dis; 2015 Feb; 24(2):394-400. PubMed ID: 25497721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.